Literature DB >> 26729463

Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells.

George C Tsokos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26729463     DOI： 10.1038/nrrheum.2015.178

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus.

Authors:  Lino L Teichmann; Jaime L Cullen; Michael Kashgarian; Chen Dong; Joe Craft; Mark J Shlomchik
Journal:  Immunity       Date:  2015-03-17       Impact factor: 31.745

Review 2.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases.

Authors:  Andras Perl
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

Review 3.  T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

4.  OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.

Authors:  Clément Jacquemin; Nathalie Schmitt; Cécile Contin-Bordes; Yang Liu; Priya Narayanan; Julien Seneschal; Typhanie Maurouard; David Dougall; Emily Spence Davizon; Hélène Dumortier; Isabelle Douchet; Loïc Raffray; Christophe Richez; Estibaliz Lazaro; Pierre Duffau; Marie-Elise Truchetet; Liliane Khoryati; Patrick Mercié; Lionel Couzi; Pierre Merville; Thierry Schaeverbeke; Jean-François Viallard; Jean-Luc Pellegrin; Jean-François Moreau; Sylviane Muller; Sandy Zurawski; Robert L Coffman; Virginia Pascual; Hideki Ueno; Patrick Blanco
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

5.  The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells.

Authors:  Peter T Sage; Alison M Paterson; Scott B Lovitch; Arlene H Sharpe
Journal:  Immunity       Date:  2014-12-05       Impact factor: 31.745

6.  Normalization of CD4+ T cell metabolism reverses lupus.

Authors:  Yiming Yin; Seung-Chul Choi; Zhiwei Xu; Daniel J Perry; Howard Seay; Byron P Croker; Eric S Sobel; Todd M Brusko; Laurence Morel
Journal:  Sci Transl Med       Date:  2015-02-11       Impact factor: 17.956

7.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

Review 8.  Pathogenesis and targeted treatment of skin injury in SLE.

Authors:  Guo-Min Deng; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

Review 9.  T cell metabolism drives immunity.

Authors:  Michael D Buck; David O'Sullivan; Erika L Pearce
Journal:  J Exp Med       Date:  2015-08-10       Impact factor: 14.307

10.  Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.

Authors:  Yan Ge; Chao Jiang; Sun-Sang J Sung; Harini Bagavant; Chao Dai; Hongyang Wang; Carol C Kannapell; Helen P Cathro; Felicia Gaskin; Shu Man Fu
Journal:  J Exp Med       Date:  2013-10-07       Impact factor: 14.307
  10 in total
  8 in total

Review 1.  Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.

Authors:  Vaishali R Moulton; Abel Suarez-Fueyo; Esra Meidan; Hao Li; Masayuki Mizui; George C Tsokos
Journal:  Trends Mol Med       Date:  2017-06-13       Impact factor: 11.951

Review 2.  Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years.

Authors:  Zachary Oaks; Thomas Winans; Nick Huang; Katalin Banki; Andras Perl
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

3.  Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.

Authors:  Liying Peng; Chanyuan Wu; Ruping Hong; Yiduo Sun; Junyan Qian; Jiuliang Zhao; Qian Wang; Xinping Tian; Yanhong Wang; Mengtao Li; Xiaofeng Zeng
Journal:  Ther Adv Musculoskelet Dis       Date:  2020-09-14       Impact factor: 5.346

Review 4.  Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.

Authors:  Frédéric Coutant; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

Review 5.  Pathogenesis and treatment of autoimmune rheumatic diseases.

Authors:  Eric Liu; Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

Review 6.  Calcium/Calmodulin Kinase IV Controls the Function of Both T Cells and Kidney Resident Cells.

Authors:  Andrew P Ferretti; Rhea Bhargava; Shani Dahan; Maria G Tsokos; George C Tsokos
Journal:  Front Immunol       Date:  2018-10-01       Impact factor: 7.561

7.  IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion.

Authors:  Katerina Gkirtzimanaki; Eleni Kabrani; Dimitra Nikoleri; Alexander Polyzos; Athanasios Blanas; Prodromos Sidiropoulos; Antonis Makrigiannakis; George Bertsias; Dimitrios T Boumpas; Panayotis Verginis
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

Review 8.  Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.

Authors:  Leila Abdelhamid; Xin M Luo
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.